Human Umbilical Cord-derived Mesenchymal Stem Cells

mesenchymal stem cells · Institute of Hematology & Blood Diseases Hospital, China

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for Human Umbilical Cord-derived Mesenchymal Stem Cells, covering 2012-03-06 to 2025-02-21. Get the full timeline:

Most recent: Clinical Trial Update: Study of Human Umbilical Cord-derived Mesenchymal Stem Cells for Treatment of Refractory Immune Thrombocytopenia [NA]

See pricing